Airway Delivery of Hydrogel-Encapsulated Niclosamide for the Treatment of Inflammatory Airway Disease
- Supplementary File 1:
ZIP-Document (ZIP, 1880 KiB)
Ousingsawat, J.; Centeio, R.; Cabrita, I.; Talbi, K.; Zimmer, O.; Graf, M.; Göpferich, A.; Schreiber, R.; Kunzelmann, K. Airway Delivery of Hydrogel-Encapsulated Niclosamide for the Treatment of Inflammatory Airway Disease. Int. J. Mol. Sci. 2022, 23, 1085. https://doi.org/10.3390/ijms23031085
Ousingsawat J, Centeio R, Cabrita I, Talbi K, Zimmer O, Graf M, Göpferich A, Schreiber R, Kunzelmann K. Airway Delivery of Hydrogel-Encapsulated Niclosamide for the Treatment of Inflammatory Airway Disease. International Journal of Molecular Sciences. 2022; 23(3):1085. https://doi.org/10.3390/ijms23031085
Chicago/Turabian StyleOusingsawat, Jiraporn, Raquel Centeio, Inês Cabrita, Khaoula Talbi, Oliver Zimmer, Moritz Graf, Achim Göpferich, Rainer Schreiber, and Karl Kunzelmann. 2022. "Airway Delivery of Hydrogel-Encapsulated Niclosamide for the Treatment of Inflammatory Airway Disease" International Journal of Molecular Sciences 23, no. 3: 1085. https://doi.org/10.3390/ijms23031085